{"groups":[{"description":"Ibrutinib PO+ Pomalidomide PO+ Dexamethasone PO\n\nIbrutinib (560mg)\n\nPomalidomide (4mg)\n\nDexamethasone (40mg)","id":"FG000","title":"Phase 1: Dose Finding (560mg)"},{"description":"Ibrutinib PO+ Pomalidomide PO+ Dexamethasone PO\n\nIbrutinib (840mg)\n\nPomalidomide (4mg)\n\nDexamethasone (40mg)","id":"FG001","title":"Phase 1: Dose Finding (840mg)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Withdrawal by Subject"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"3"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"3"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}